271-280 of 286 results
No relief in PBS price changes for originators seeking injunctions
Patentees may face heightened risks when changes to the Pharmaceutical Benefits Scheme (PBS) take effect later this year. Special Counsel Ric Morgan and Associate Claire Gregg explain. ...
Nurofen maker in need of fast pain relief
Paracetamol manufacturer Hence Reckitt Benckiser has discovered that inaccurate and unbalanced comparative claims that don't reflect the overall picture can cause big headaches, even where those claims have some support. ...
Changes to Australia's IP laws are on the way
IP Australia has released draft legislation implementing the Federal Government's response to the Productivity Commission's inquiry into IP arrangements. ...
Will Ed Sheeran be facing copyright lawsuits for The Rest of Our (or his) Life?
It's a new year and, in what is seemingly becoming an annual tradition, a new copyright infringement lawsuit has been filed against pop superstar Ed Sheeran. ...
A tender approach to genetic testing
The year has got off to a good start for innovators, with the Federal Court providing some assurance that methods of genetic testing continue to be patentable in Australia. But tender news for some can be a tough outcome for others. ...
Reasonable belief or a mere suspicion? Full Court lowers the bar on preliminary discovery applications
The Full Federal Court has handed down a significant decision on preliminary discovery in a result that will be welcomed by IP owners, as the court has clarified the requirements for a successful preliminary discovery application while emphasising the need for such applications to be met with brevit ...
Looks can be deceiving: deceptive similarity, substantial identity and trade mark infringement
This Insights examines the interpretative requirements for determining a trade mark infringement ...
Full Federal Court overturns decision allowing patent term extension of 'Swiss-style' claims
The Full Federal Court has unanimously held that patent term extensions are not available for second medical use claims involving the use of recombinant DNA technology This decision overturns a controversial finding of the Administrative Appeals Tribunal last year and means that any patent term ...
Trade mark owners beware
The Full Federal Court has put trademark owners in Australia making it clear that when trade mark applications are filed in the incorrect name, the defect is fatal. Accordingly, it is vital that trade mark owners conduct a critical analysis of their trade mark portfolios and ensure that valid rights ...
Protecting innovation without patents - data exclusivity and market exclusivity
Developments in patent law and the consequential limitations on patentability for biologic medicines mean that data exclusivity and market exclusivity can be the primary protection afforded to originator biologic medicines This is most stark in the US where patent protection for biologic medicines ...